Get Silicon Valley Top 1000 Contacts List

Buy the List or Request a Demo

Corcept Therapeutics

Verified by our team

  • Biotechnology
Linkedin Twitter Facebook

Corcept is a leader in cortisol modulation, developing selective glucocorticoid receptor (GR) antagonists to treat serious diseases. With over 25 years of research, including the FDA-approved treatment for Cushing’s syndrome, Corcept is pioneering advancements in oncology, endocrine, and metabolic disorders through global partnerships and innovative therapies.

Corcept Therapeutics Highlights:

  • Corcept Therapeutics annual revenue is $569.6M.
  • Corcept Therapeutics total funding is $722.2B.
  • Corcept Therapeutics headquartered in Redwood City, California.
  • Corcept Therapeutics number of employees is 470.

    • Overview

    • Website: corcept.com
    • Headquarters: Redwood City, California
    • Employees: 470
    • Founded: 1998
    • Email: info@corcept.com
    • Funding: $722.2B
    • Revenue: $569.6M
    • Valuation: n/a

    Contacts

    Atabak Mokari

    CFO
    Linkedin
    • Email: ***@corcept.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to Corcept Therapeutics

    Corcept Therapeutics is located in Redwood City, California.
    Yes, Corcept Therapeutics is a Silicon Valley company.
    Corcept Therapeutics total funding is 722.2B.
    Corcept Therapeutics revenue is 569.6M.
    Corcept Therapeutics’s number of employees is 470.
    Corcept Therapeutics’s CEO name is Atabak Mokari.
    Corcept Therapeutics was founded in 1998.
    Corcept Therapeutics’s contact email is info@corcept.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ